Introduction {#s1}
============

Lyme disease is a multisystem illness that, in North America, is caused by the spirochete *Borrelia burgdorferi* sensu stricto (hereafter referred to as *B. burgdorferi*) which is transmitted to humans through the bite of infected *Ixodes* spp. ticks [@pone.0073066-Dennis1]. In the United States, Lyme disease remains the leading cause of all vector-borne human infections with more than 20,000 annually reported cases [@pone.0073066-Center1]. The risk of infection is highly localized within 12 states in the northeastern and upper Midwestern regions accounting for 94% of all reported cases [@pone.0073066-Center1]. Clinical features of human infection can include a wide variety of symptoms ranging from a characteristic skin lesion known as erythema migrans often seen during the early stages of disease to more severe musculoskeletal, neurologic or cardiovascular manifestations of disseminated infection that arise from hematogenous dissemination from the initial site of inoculation in the skin [@pone.0073066-Wormser1], [@pone.0073066-Wormser2].

Substantial genetic diversity exists within *B. burgdorferi* [@pone.0073066-Attie1]--[@pone.0073066-Hanincova1]. The plasmid-borne, highly polymorphic outer surface protein C gene (*ospC*) and the 16 S--23 S (*rrs-rrl*) rRNA intergenic spacer (IGS) have been the most commonly used genetic markers for *B. burgdorferi* strain identification in the US [@pone.0073066-Bunikis1], [@pone.0073066-Qiu1], [@pone.0073066-Wang1]--[@pone.0073066-Hanincova2]. It has been observed that strains exhibiting restriction fragment length polymorphism in the 16 S--23 S rRNA intergenic spacer designated as RST1 or possessing *ospC* major groups A, B, H, I and K have a stronger tendency for hematogenous dissemination early in the course of disease [@pone.0073066-Seinost1], [@pone.0073066-Jones1], [@pone.0073066-Wormser3]--[@pone.0073066-Earnhart1]. This observation gave rise to the concept that a distinct subset of *B. burgdorferi* genotypes is responsible for early disseminated infection in humans, suggesting that some degree of differential pathogenicity exists among strains. Both RST and *ospC* typing methods provide a useful tool for categorizing *B. burgdorferi* strains that vary in their tendency to disseminate in humans. Neither method, however, is suitable for inferring intraspecific relationships among strains that are important for understanding the evolution of pathogenicity and the geographical spread of disease. While RST typing has limited discriminatory power for this purpose [@pone.0073066-Hanincova1], [@pone.0073066-Brisson2] the suitability of *ospC* typing may also be restricted since the highly variable *ospC* gene is subject to recombination and horizontal gene transfer, as well as strong selection by the host immune system [@pone.0073066-Margos1], [@pone.0073066-Barbour1], [@pone.0073066-Spratt1]--[@pone.0073066-Haven1]. Moreover, phylogenetic analysis of a single locus can often result in erroneous inference of evolutionary relationships [@pone.0073066-Maiden1], [@pone.0073066-Maiden2].

The most appropriate of the current techniques for large-scale epidemiology, strain identification and understanding of the population structure of bacterial species is multilocus sequence typing (MLST). This method is based on nucleotide sequences of multiple housekeeping genes that are evolving nearly neutrally. MLST analysis has been used successfully to study a number of bacteria (<http://www.mlst.net> and <http://www.pubmlst.org>) and has been employed to identify lineages of particular clinical relevance in bacterial pathogens such as *Neisseria meningitidis* [@pone.0073066-Maiden1], [@pone.0073066-Jolley1], *Streptococcus pneumoniae* [@pone.0073066-Enright1], [@pone.0073066-Zhou1], *Staphylococcus aureus* [@pone.0073066-Enright2]--[@pone.0073066-Feil1], *Campylobacter jejuni* [@pone.0073066-Dingle1]--[@pone.0073066-Wareing1] and *Bartonella henselae* [@pone.0073066-Arvand1]. An MLST method based on eight housekeeping loci providing a high degree of intraspecies discriminatory power has been recently developed and validated for *B. burgdorferi* [@pone.0073066-Margos1]. This MLST typing scheme has been employed to examine the population structure of *B. burgdorferi* in *Ixodes scapularis* and *Ixodes pacificus*, the principal vectors of Lyme disease in North America [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. To date, however, MLST has not been used to assess the population structure of clinically relevant strains of *B. burgdorferi*.

In this study, MLST was used for the first time to explore the population structure of *B. burgdorferi* isolated from Lyme disease patients. The genetic diversity of clinical isolates was assessed, and the genetic and evolutionary relationships between strains found in patients with localized versus disseminated infection, and in patients from two different geographical locations in the US, New York and Wisconsin, were evaluated. The data suggest the existence of *B. burgdorferi* lineages with differential pathogenic properties in humans.

Results {#s2}
=======

MLST and Identification of Clonal Complexes {#s2a}
-------------------------------------------

MLST analysis of 146 *B. burgdorferi* isolates recovered from Lyme disease patients in New York and Wisconsin revealed 53 sequence types (STs) ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"}); 23 have been previously identified and reported [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. Twenty-two of the 53 STs were represented by only a single isolate, while the number of isolates belonging to other STs ranged from 2 to 8 ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"}). A goeBURST analysis, performed including previously published STs from the northeastern and upper midwestern US and adjoining areas of Canada, grouped the new STs into eleven major clonal complexes, five of which were new (CC4, CC16, CC226, CC55 and CC228) and six of which (CC7, CC12, CC19, CC34, CC36 and CC37) were described previously [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. Three minor clonal complexes and 14 singletons were also identified ([Figure 1](#pone-0073066-g001){ref-type="fig"}). Two of the eleven major clonal complexes (CC37 and CC55) were clearly characterized as highly supported terminal clusters on a phylogenetic tree constructed from concatenated sequences of the eight MLST genes ([Figure 2](#pone-0073066-g002){ref-type="fig"}). CC36, CC12, CC16 and CC19 also formed clusters on the tree, but did not attain sufficient statistical support (\>70% on the MP tree and aLRT \>0.9 on the ML tree). CC4 and CC34 included STs that were placed outside their main cluster on the tree ([Figure 2](#pone-0073066-g002){ref-type="fig"}). Further examination of ST396 (an outlier in CC4) and ST4 (the inferred founder of CC4) revealed that three variant loci (*clpA*, *pyrG* and *uvrA*) differed at multiple sites (6, 2 and 3, respectively), resulting in a total of 11 polymorphisms, which on the tree led to the separation of ST396 from the other STs assigned to CC4. Similarly, the comparison of ST52 (an outlier in CC34) and ST34 (the inferred founder of CC34) revealed seven polymorphisms in the *clpA* locus, which resulted in the separation of ST52 (and its descendants) from the other STs assigned to CC34.

![A population snapshot of *B. burgdorferi* in the northeastern and midwestern United States and Canada.\
The snapshot comprises of 88(420 human and tick samples) and was created by goeBURST v1.2 using data from this study and the previously published data sets downloaded from <http://borrelia.mlst.net/> [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. Circle size and color correspond to MLST sample size and the source, respectively. Gray, strains found in ticks; white, strains found in humans. Colored lines connecting STs indicate descending order of certainty; black lines are inferred without tiebreak rules, blue lines are inferred using tiebreak rule 1 (number of SLV), and green lines are inferred using tiebreak rule 2 (number of DLV). STs connected by a black line are single locus variants and STs connected by gray line are double locus variants. The inferred founders of clonal complexes are numbered in bold. STs found in patients with localized infection are outlined in green, those found in patients with disseminated infection are outlined in red, those found in both patients with localized and patients with disseminated infection are outlined in orange and those found in patients with undetermined clinical status are outlined in black. STs that are not outlined were only found in ticks. The *ospC* major groups are shown for all 53 STs which were found in humans.](pone.0073066.g001){#pone-0073066-g001}

![Unrooted ML tree of *B. burgdorferi* based on concatenated sequences of eight MLST housekeeping genes.\
The tree was created using data from this study and the previously published data sets downloaded from <http://borrelia.mlst.net/> [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. A total of 420 *B. burgdorferi* samples (88 STs) found in humans and ticks from the northeastern United States and Canada were used. The aLRT statistical values and nonparametric bootstrap values for highly supported nodes in both maximum parsimony (with \>70% support) and maximum likelihood (with aLRT \>0.9 support) are indicated above and below the branches, respectively. STs newly identified in this study are in bold. The grouping of STs into major clonal complexes (CCs) is indicated by right brackets. The STs found only in humans are shown in blue, those found only in ticks are shown in red and those found in both humans and ticks are shown in green. The type of infection is indicated next to the ST using solid square (ST found in patients with localized infection), solid triangle (ST found in patients with disseminated infection) and solid diamond (ST found in both patients with localized and patients with disseminated infection). Geographical origin of STs found in humans and identified in this study is indicated in brackets next to the STs (NY -- New York; WI -- Wisconsin).](pone.0073066.g002){#pone-0073066-g002}

Relationship between *ospC* Major Groups and STs {#s2b}
------------------------------------------------

For 29 of 31 STs that contained ≥2 isolates there was a perfect congruence between ST and *ospC* major group. In the other two STs (ST3 and ST55) a single isolate possessed an *ospC* major group different from the other isolates ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"} and [Figure 1](#pone-0073066-g001){ref-type="fig"}). However, closely related STs did not always exhibit the same *ospC* major group. Seven out of 11 major clonal complexes (CC4, CC12, CC19, CC34, CC36, CC37 and CC55) contained STs of different *ospC* major groups ([Figure 1](#pone-0073066-g001){ref-type="fig"}). Furthermore, only three (L, O and F3) out of 20 *ospC* major groups that contained ≥2 isolates were restricted to a single ST; the remaining *ospC* major groups were associated with multiple STs. The *ospC* major groups distributed among the largest number of STs were N (6 STs), I (5 STs) and F (4 STs). In addition, *ospC* major groups F, I, N and U were shared by isolates of different major clonal complexes ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"} and [Figure 1](#pone-0073066-g001){ref-type="fig"}). By definition, *ospC* major groups can contain closely related alleles that differ from each other in less than 2% of their nucleotide sequence [@pone.0073066-Wang1]. To assess whether the *ospC* sequences would allow further differentiation between STs and major clonal complexes, we compared sequences of isolates within 17 *ospC* major groups that were associated with multiple STs. Nine *ospC* major groups, including N and I, that were associated with the greatest number of STs were represented by a single *ospC* allele. *ospC* major groups D, F, H and M contained two or more *ospC* alleles, some of which were shared by multiple STs. However, with exception of *ospC* major group M, isolates belonging to the same ST possessed identical *ospC* alleles. *ospC* major groups C, E, U and E3 were each represented by two *ospC* alleles, each of which were associated with different STs, but some of these STs were represented by only one isolate ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"}).

Geographical Distribution of STs and *ospC* Major Groups Found in Lyme Disease Patients {#s2c}
---------------------------------------------------------------------------------------

Out of 146 patients, 76 were from New York and 70 from Wisconsin. Patients from Wisconsin appeared to have a higher ST diversity (n = 35) than patients from New York (n = 20). Only two STs (ST4 and ST12) were found in both geographical locations ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"} and [Figure 3A](#pone-0073066-g003){ref-type="fig"}). Despite the almost entirely non-overlapping ST distribution ([Figure 3A](#pone-0073066-g003){ref-type="fig"}), the STs from New York patients clustered together with STs from Wisconsin patients on well-supported nodes in the ML tree. For example, ST18 and ST37 found only in patients from New York formed a strongly supported cluster with ST47 and ST223 found only in patients from Wisconsin ([Figure 2](#pone-0073066-g002){ref-type="fig"}). Furthermore, the genetic relatedness of the two populations was corroborated by a permutation test using the allelic profiles of these isolates (multiple response permutation procedure, P\>0.05). In addition, all clonal complexes consisted of STs from both geographical locations.

![Venn diagrams depicting the geographical distribution of *B. burgdorferi* in Lyme disease patients.\
A) Geographical distribution of *B. burgdorferi* STs found in Lyme disease patients from New York and Wisconsin. B) Geographical distribution of *B. burgdorferi ospC* major groups identified in skin samples of Lyme disease patients from New York and Wisconsin.](pone.0073066.g003){#pone-0073066-g003}

The diversity and frequency distribution of *ospC* major groups in Wisconsin patients (65 skin isolates cultured during 1995 to 2003) was compared with 291 previously genotyped skin isolates obtained from New York patients during 1991 to 2005 [@pone.0073066-Hanincova1], [@pone.0073066-Wormser4] ([Table 1](#pone-0073066-t001){ref-type="table"}). A greater diversity of *ospC* major groups was observed in skin isolates from Wisconsin (n = 22) than those from New York (n = 17) ([Table 1](#pone-0073066-t001){ref-type="table"}). While all *ospC* major groups found in skin isolates from New York were also found in skin isolates from Wisconsin, *ospC* major groups L, X, Y, B3 and F3 were found only in skin isolates from Wisconsin ([Table 1](#pone-0073066-t001){ref-type="table"}, [Figure 3B](#pone-0073066-g003){ref-type="fig"}). The frequency distribution of *ospC* major groups differed significantly between skin isolates from New York and Wisconsin (correspondence analysis, χ2 = 119.88, P\<0.001, [Table S2](#pone.0073066.s003){ref-type="supplementary-material"}). The most common *ospC* major groups found in the skin isolates from New York were K, A, B and I which constituted 64.9% of all infections. In contrast, the most common *ospC* major group found in the skin isolates from Wisconsin was H, which constituted 18.5% of all infections.

10.1371/journal.pone.0073066.t001

###### Geographical distribution of *B. burgdorferi ospC* major groups found in skin of Lyme disease patients from New York and Wisconsin.

![](pone.0073066.t001){#pone-0073066-t001-1}

                                              *ospC* major groups[b](#nt102){ref-type="table-fn"}                                                                                                
  ------------------------------------------ ----------------------------------------------------- ---- --- --- ---- ---- ---- ---- ---- --- ---- --- ---- ---- --- --- ---- --- --- --- --- --- -----
  New York[a](#nt101){ref-type="table-fn"}                            46                            37   2   4   14   9    14   13   20   3   86   0   11   17   1   2   11   0   0   0   1   0   291
  Wisconsin                                                            2                            2    2   4   2    4    3    12   2    1   4    5   2    3    3   2   3    1   1   4   1   2   65
  Total                                                               48                            39   4   8   16   13   17   25   22   4   90   5   13   20   4   4   14   1   1   4   2   2   356

New York data (n = 290) based on [@pone.0073066-Wormser4]. One additional isolate (E3) was added from [@pone.0073066-Hanincova1].

*ospC* major group designation according to [@pone.0073066-Barbour1], [@pone.0073066-Wang1]. *ospC* major groups X and Y were not published at the time this article was written but are available in GenBank under accession numbers HM047876 and HM047875 respectively.

Characteristics of Clinical Isolates, STs and Clonal Complexes {#s2d}
--------------------------------------------------------------

Data with regard to disseminated and localized infection were available for 127 isolates ([Table S1](#pone.0073066.s002){ref-type="supplementary-material"}). These isolates were divided by MLST into 51 STs. Of these, 41 linked to eleven major and three minor clonal complexes, and 10 were identified as singletons ([Table 2](#pone-0073066-t002){ref-type="table"} and [Figure 1](#pone-0073066-g001){ref-type="fig"}). Out of the 27 STs that were represented by ≥2 isolates with available clinical data, we found 17 in patients with both disseminated and localized infection ([Table 3](#pone-0073066-t003){ref-type="table"}). While the association between type of infection and ST bordered on significant (total inertia = 0.522, χ^2^ = 65.84, P = 0.066), there was a significant association between type of infection and clonal complexes in each of three separate statistical analyses. The first analysis included major and minor clonal complexes as well as singletons (total inertia = 0.369, χ^2^ = 46.55, P = 0.003); in the second analysis, singletons were excluded (total inertia = 0.349, χ^2^ = 42.61, P = 0.001); and for the third analysis only major clonal complexes were included (total inertia = 0.329, χ^2^ = 33.60, P = 0.001) ([Table 2](#pone-0073066-t002){ref-type="table"} and [Figure S1](#pone.0073066.s001){ref-type="supplementary-material"}). In each scenario CC37 was clearly associated with localized infection and CC4 showed a tendency to include mainly isolates from patients with disseminated infections. CC7 and CC16 were also associated with disseminated infection, although the number of isolates within these clonal complexes was too small to draw any definite conclusions ([Table 2](#pone-0073066-t002){ref-type="table"} and [Figure S1](#pone.0073066.s001){ref-type="supplementary-material"}). *ospC* major groups were also significantly associated with type of infection, but in each case using the full data, and reduced data as described above, *ospC* groups appeared less predictive than clonal complexes; *ospC*-based analyses had lower inertia and χ^2^ values and/or higher P values (inertia = 0.303, 0.281, 0.336; χ^2^ = 38.14, 34.34, 34.29; and P = 0.012, 0.017 and 0.008, respectively, for the three analyses). *ospC* major groups B, H and K were particularly associated with disseminated infection and *ospC* major groups F and T were significantly associated with localized infection ([Figure S1](#pone.0073066.s001){ref-type="supplementary-material"}). Further, MLST allowed additional discrimination between isolates with differential disseminative properties that belonged to a single *ospC* major group. For example, all *ospC* major group U isolates in CC37 were cultured from patients with localized infection, whereas the only *ospC* major group U isolate that was cultured from a patient with a disseminated infection was a member of a different clonal complex (CC36). Similarly, *ospC* major group K isolates in CC4 were obtained from patients with disseminated infection; two *ospC* major group K isolates cultured from patients with localized infection were not members of CC4. An *ospC* major group B isolate from a patient with localized infection was not part of CC7, a clonal complex that is comprised only of *ospC* major group B isolates from patients with disseminated infection. *ospC* major group I isolates were divided between two different major clonal complexes. CC16 contains *ospC* major group I isolates cultured from patients with disseminated infection and CC228 is comprised of *ospC* major group I isolates cultured from patients with localized skin infection ([Figure 1](#pone-0073066-g001){ref-type="fig"}, [Table S1](#pone.0073066.s002){ref-type="supplementary-material"}). The discriminatory power of *ospC* did not improve much by considering the specific *ospC* sequence, as all isolates within *ospC* major groups B, I and K had identical *ospC* sequences.

10.1371/journal.pone.0073066.t002

###### Distribution of *B. burgdorferi* isolates from Lyme disease patients with localized and disseminated infection between clonal complexes and singletons.

![](pone.0073066.t002){#pone-0073066-t002-2}

                    Number of Isolates       
  ---------------- -------------------- ---- -----
  **CC4**                   6            18   24
  **CC7**                   0            4     4
  **CC12**                  5            6    11
  **CC16**                  0            3     3
  **CC19**                  9            4    13
  **CC34**                  7            4    11
  **CC36**                  6            6    12
  **CC37**                  11           0    11
  **CC55**                  2            2     4
  **CC226**                 3            0     3
  **CC228**                 2            0     2
  **CC38--318**             1            1     2
  **CC56--231**             2            0     2
  **CC237--394**            1            0     1
  **S1**                    1            4     5
  **S11**                   0            3     3
  **S29**                   1            3     4
  **S30**                   1            1     2
  **S40**                   1            0     1
  **S225**                  2            0     2
  **S234**                  3            1     4
  **S235**                  1            0     1
  **S236**                  0            1     1
  **S412**                  1            0     1
  **Total**                 66           61   127

10.1371/journal.pone.0073066.t003

###### Distribution of *B. burgdorferi* STs between Lyme disease patients with disseminated and localized infection.

![](pone.0073066.t003){#pone-0073066-t003-3}

                          STs[a](#nt103){ref-type="table-fn"}                                                                                                  
  ------------------ --- ------------------------------------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  **Localized**       1                    0                    1   0   4   0   0   4   4   6   3   1   1   4   1   2   1   1   2   1   1   1   2   1   2   2   2
  **Disseminated**    4                    4                    7   3   1   3   3   4   1   0   3   3   1   4   2   0   1   1   0   2   2   1   0   3   0   0   1
  **Total**           5                    4                    8   3   5   3   3   8   5   6   6   4   2   8   3   2   2   2   2   3   3   2   2   4   2   2   3

Only STs that are represented by ≥2 isolates with available clinical data are shown.

STs, sequence types.

Discussion {#s3}
==========

Accurate strain identification of pathogenic bacteria is essential for epidemiological surveillance and permits effective public health decisions. Previously, MLST based on eight housekeeping loci was exploited to examine *B. burgdorferi* population structure in *Ixodes* spp. ticks and provided novel insights into the phylogeography of the pathogen [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. Moreover, MLST has been shown to detect ecologically distinct groups within *B. garinii* (i.e., a bird-associated ecotype and a rodent-associated ecotype) [@pone.0073066-Margos3] indicating that this typing method has the power to detect and demarcate phenotypic differences of ecological significance among Lyme disease spirochetes. The present study represents the first application of this MLST scheme for analysis of the *B. burgdorferi* population structure in patients with Lyme disease, and the results indicate that phylogeny and pathogenicity of *B. burgdorferi* are correlated.

Numerous *B. burgdorferi* genotypes have been previously characterized among isolates obtained from Lyme disease patients in the northeastern US, primarily using the *rrs-rrlA* IGS and *ospC* loci [@pone.0073066-Hanincova1], [@pone.0073066-Wormser4]--[@pone.0073066-Strle1], [@pone.0073066-Nadelman1]--[@pone.0073066-Brisson3]. An association of certain *rrs-rrlA* and *ospC* genotypes with early dissemination has been observed [@pone.0073066-Jones1], [@pone.0073066-Wormser3]--[@pone.0073066-Dykhuizen1], [@pone.0073066-Earnhart1], but the specific determinants facilitating dissemination remain unknown. The differences in disease severity and dissemination properties between different *B. burgdorferi* genotypes have been experimentally corroborated for selected strains in C3H/HeJ mice [@pone.0073066-Wang3], [@pone.0073066-Wang4]. The MLST analysis confirmed the high degree of genetic heterogeneity of *B. burgdorferi* in Lyme disease patients indicating that a wide range of *B. burgdorferi* strains is capable of infecting humans. Clinical isolates were represented in all the identified clonal complexes suggesting that there is no link between MLST genotype and the propensity to cause human infection *per se*. However, there was an association of certain clonal complexes with the type of infection (i.e., disseminated vs. localized) suggesting that some clonal complexes of *B. burgdorferi* may have a greater propensity for hematogenous dissemination, while others, such as members of CC37, may be capable of only causing localized skin infection. Analysis of the population structure using much larger data sets, in combination with careful epidemiological sampling, is required to better understand the relationship between dissemination potential and clonal complex.

Interestingly, the data indicate that the power of MLST to predict the outcome of infection (i.e., localized or disseminated) was greater than that of *ospC* typing, suggesting that the pathogenic traits of *B. burgdorferi* correlate with the phylogenetic signal. Thus, association between *ospC* major groups and dissemination properties may be indirect and operate via strong linkage disequilibrium [@pone.0073066-Attie1], [@pone.0073066-Bunikis1], [@pone.0073066-Barbour1], [@pone.0073066-Hanincova1], [@pone.0073066-Brisson3]. Indeed, studies in mice have shown that OspC is a factor essential for initial establishment of infection in mammals, but it is also an effective immune target that must be down-regulated after the initiation of infection so as to prevent spirochete clearance [@pone.0073066-Tilly1], [@pone.0073066-Earnhart2]. The ability of *B. burgdorferi* strains to cause disseminated infection in humans is a phenotypic characteristic of unknown origin. It is likely that *B. burgdorferi* interactions with its vectors and natural reservoir hosts throughout a long evolutionary course resulted in genotypes which in the human body display either disseminative or non-disseminative properties. Therefore, further studies of the evolutionary origins of different clonal complexes may help to predict the spatial and temporal occurrence of pathogenic *B. burgdorferi* strains.

Previously, *ospC* major groups A, B, H, I and K, isolated from patients in New York, have been identified predominantly as invasive genotypes, while some *ospC* major groups including T and U have been associated with localized skin infection [@pone.0073066-Seinost1], [@pone.0073066-Wormser3], [@pone.0073066-Wormser4]. Consistent with the *ospC* studies, isolates within CC37, associated with localized skin infection, belonged to either *ospC* major groups T or U, all but one isolate found in CC4, associated with disseminated infection, belonged to either *ospC* major groups K or H and all isolates within CC7 and CC16 that were also associated with disseminated infection were identified as members of *ospC* major groups B and I, respectively. In addition, isolates that belonged to a single *ospC* major group (e.g. B, I, K or U), but exhibited different dissemination properties, were further divided among distinct clonal complexes or clonal complexes and singletons. These differences could be explained by horizontal gene transfer and recombination at *ospC* that over time would result in the dissociation of *ospC* major groups from genes which contribute to the ability to disseminate. A number of studies provide genetic evidence of recombination and horizontal gene transfer at *ospC* [@pone.0073066-Margos1], [@pone.0073066-Barbour1], [@pone.0073066-Hanincova1], [@pone.0073066-Wang2], [@pone.0073066-Haven1], [@pone.0073066-Lin1]. While the mechanisms underlying these processes in nature are unknown, mixed infections in the tick or host, that would be required for genetic exchange, have been documented [@pone.0073066-Qiu1], [@pone.0073066-Hoen1], [@pone.0073066-Bunikis2]--[@pone.0073066-Hamer1].

It has been suggested that the *B. burgdorferi* population structure is dominated by frequency dependent selection acting at *ospC* [@pone.0073066-Qiu1]--[@pone.0073066-Wang1]. Based on this, and the strong linkage disequilibrium observed between *ospC* and other genomic markers, it has been proposed that *ospC* is a lineage-defining gene [@pone.0073066-Haven1]. While at a certain scale a strong association between *ospC* and various chromosomal and/or plasmid-encoded loci [@pone.0073066-Attie1], [@pone.0073066-Bunikis1], [@pone.0073066-Barbour1], [@pone.0073066-Qiu1], [@pone.0073066-Hanincova1] has been shown, this linkage proved not to be absolute at a wider spatial scale [@pone.0073066-Barbour1], [@pone.0073066-Margos2], [@pone.0073066-Qiu3]. The present results, based on concatenated sequences of eight housekeeping genes suggest that *B. burgdorferi* is not subdivided in a manner that corresponds to *ospC* major groups. First, almost all *ospC* major groups were associated with multiple STs. Second, although most STs were comprised predominantly of isolates with the same *ospC* major group, related STs were assembled into clonal complexes that did not reflect a simple clonal descent of *ospC* major group within *B. burgdorferi* lineages. Taken together, the data indicate that while *ospC* major group may be a relatively stable characteristic of a ST, the use of *ospC* typing as a means of strain identification for epidemiological, ecological and population genetic studies is not reliable.

Patients from New York and Wisconsin were infected with two distinct, but genetically and phylogenetically closely related, populations of *B. burgdorferi*. Only two STs were identified in patients from both locations. The presence of identical *B. burgdorferi* STs in *I. scapularis* ticks from the Northeast and Upper Midwest of North America have been previously explained as either a reminiscence of once overlapping populations of *B. burgdorferi* or the result of limited gene flow [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. Geographical structuring of *B. burgdorferi* in Lyme disease patients from New York and Wisconsin captured by MLST in this study was similar to that previously reported in *I. scapularis* questing ticks from the Northeast and Upper Midwest of North America [@pone.0073066-Margos2], [@pone.0073066-Hoen1]. The mirroring geographic patterns of *B. burgdorferi* in humans and *I. scapularis* ticks are not surprising given that infection is acquired peri-domestically by *I. scapularis* tick bites [@pone.0073066-Maupin1], [@pone.0073066-Falco1]. In contrast to MLST, and in concordance with other studies, *ospC* did not provide a clear signal of geographical structuring of *B. burgdorferi* [@pone.0073066-Brisson2], [@pone.0073066-Ogden1], [@pone.0073066-Margos2], [@pone.0073066-Travinsky1]. While there was a significantly different frequency distribution of *ospC* major groups between patients from New York and those from Wisconsin, the vast majority of *ospC* major groups infected patients in both regions. It is conceivable that due to evolution of *ospC* in ancestral spirochete populations and balancing selection [@pone.0073066-Qiu1]--[@pone.0073066-Wang1], [@pone.0073066-Dykhuizen2], [@pone.0073066-Qiu4], [@pone.0073066-Kurtenbach1] geographic structuring of *ospC* major groups may be more obscure than that observed at MLST loci. Nevertheless, a large-scale geospatial analysis of *ospC* sequences from *I. scapularis* ticks demonstrated that despite a substantial overlap of *ospC* types in northeastern and midwestern populations, differences in frequency distribution allowed a subdivision at the longitude of 83°W [@pone.0073066-Barbour1]. Given the differences in clinical outcomes associated with specific genotypes, the spatial differences of *B. burgdorferi* observed at the MLST and *ospC* levels and its epidemiological implications warrant further investigation.

The MLST analysis performed in this study suggests that recombination was likely to generate some of the *B. burgdorferi* diversity at the MLST loci. For example, ST52 strains possess a *clpA* allele that differs from its ancestral *clpA* allele at seven nucleotide positions and is shared by two STs that are members of different clonal complexes. It is very unlikely that seven independent point mutations would accumulate at a single locus while no changes would be present on the other seven loci, and that two unrelated STs would share alleles that arose by accumulation of seven point mutations. It can, therefore, be assumed that this allele arose through recombination rather than point mutation [@pone.0073066-Feil2]. Indeed, genetic evidence of recombination has been recently reported for the *B. burgdorferi* chromosome suggesting that apart from mutation and genetic drift, recombination may also have some impact on the diversification of *B. burgdorferi* [@pone.0073066-Haven1], [@pone.0073066-Vitorino1]. While it is known that recombination may obscure phylogenetic signals, the definition of clonal complexes via goeBURST on the basis of allele identity (an integer) rather than sequence diversity [@pone.0073066-Feil3] tends to yield discrete clusters of related organisms that appear to be stable over decades, if not centuries, even at medium levels of homologous recombination [@pone.0073066-Turner1], [@pone.0073066-Feil4].

In conclusion, MLST analysis of *B. burgdorferi* strains isolated from Lyme disease patients suggests the existence of *B. burgdorferi* lineages with differential pathogenic properties in humans. The data indicate that MLST strain identification is better suited for epidemiological, ecological and population genetics studies than is *ospC* typing and suggest that MLST provides finer resolution of differentially pathogenic *B. burgdorferi* strains than does *ospC* typing. The results further demonstrate that humans in New York and Wisconsin are infected with two separate, but genetically related, populations of *B. burgdorferi*. While the data provide new and important insights into the population structure of *B. burgdorferi*, a much larger collection of diverse isolates must be examined to better understand the full extent of *B. burgdorferi* strain diversity and population structure in Lyme disease patients, and relationships between human disease, STs and clonal complexes.

Materials and Methods {#s4}
=====================

Ethics Statement {#s4a}
----------------

All human subjects from New York were enrolled in prospective studies approved by the Institutional Review Board (IRB) of New York Medical College for which they had provided written informed consent at the Lyme Disease Diagnostic Center between 1991 and 2006. Samples and data from Wisconsin patients were collected in the past as a part of routine care/diagnostic testing and were accessed under approved IRB protocols of the Marshfield Clinic Research Foundation. A waiver of informed consent has been granted by the IRB. All data were analyzed anonymously.

Clinical Isolates {#s4b}
-----------------

A total of 146 *B. burgdorferi* clinical isolates recovered from 146 Lyme disease patients (i.e., a single isolate per patient) from New York and Wisconsin (states located in the northeastern and upper Midwestern regions of US, respectively) were analyzed in this study. Seventy six isolates were cultured from erythema migrans lesions (n = 60) or blood (n = 16) of patients diagnosed at the Lyme Disease Diagnostic Center at New York Medical College in Valhalla, NY between 1991 and 2005, and 70 isolates were recovered from erythema migrans skin lesions (n = 65) or cerebrospinal fluid specimens (n = 5) of patients diagnosed at the Marshfield Clinic in Wisconsin between 1993 and 2003. Specimens were collected and cultured as described elsewhere [@pone.0073066-Wormser3], [@pone.0073066-Wang5]--[@pone.0073066-Mitchell1].

The New York isolates analyzed in this study belong to a large collection of more than 400 clinical isolates that had been previously typed at the *rrs-rrl*A IGS and *ospC* loci [@pone.0073066-Hanincova1], [@pone.0073066-Wormser3], [@pone.0073066-Wormser4]. Therefore, to better cover the full diversity of *B. burgdorferi* genotypes found in the collection, 3 to 7 isolates per *ospC* major group were selected for this study. For those *ospC* major groups that consisted of isolates from skin and blood, representatives from both were included. No preselection was made for the Wisconsin isolates.

Patients included in this study were diagnosed with early Lyme disease and were classified as having either localized or disseminated infection. Localized infection was defined by a single culture positive erythema migrans skin lesion in the absence of a positive blood culture or clinical and/or microbiological evidence of dissemination to a second site. Disseminated infection was defined by a positive blood or cerebrospinal fluid culture, multiple erythema migrans lesions and/or neurological findings.

DNA Extraction and MLST {#s4c}
-----------------------

DNA from low-passage (passages 1 to 5) *B. burgdorferi* was isolated from the clinical samples with either the IsoQuick kit (Orca Research, Bothell, WA) or the Gentra PureGene DNA Isolation Kit (Qiagen Inc., Valencia, CA). Eight housekeeping loci (*clpA*, *clpX*, *nifS*, *pepX*, *pyrG*, *recG*, *rplB*, and *uvrA*) were amplified by nested PCR and sequenced using PCR primers in both directions (Genewiz, Inc., South Plainfield, NJ) as described previously [@pone.0073066-Margos1]. Quality control of DNA traces was conducted manually in DNASTAR (Lasergene plc, USA). Isolates that produced ambiguous sequence results were cloned by limiting dilution and sequencing of all eight loci were performed on two clones from each isolate. Samples that still produced ambiguous sequence results were considered mixed and removed from further analysis. Sequences of individual genes were compared to each other and to sequences in the MLST database. Existing sequences were assigned allelic numbers and new sequences were automatically assigned consecutive allele numbers by the MLST database. New consecutive sequence type (ST) numbers were assigned to allelic profiles with novel combinations. All alleles and STs are accessible at the MLST website (<http://www.borrelia.mlst.net/>) hosted at Imperial College London (London, UK). STs of 23 clinical isolates used in this study have been previously reported [@pone.0073066-Margos1].

*ospC* Analysis {#s4d}
---------------

To determine the *ospC* genotypes of Wisconsin clinical isolates, the *ospC* gene was amplified by PCR using OC6 (+) and OC623 (−) primers as described previously [@pone.0073066-Qiu1] and the PCR products were sequenced in both directions (Genewiz, Inc., South Plainfield, NJ). The sequence quality control and further analysis of unambiguous sequence results were performed as described above. To determine the major *ospC* groups, the *ospC* sequences were compared to existing sequences of major *ospC* groups found worldwide, according to the previously defined criteria [@pone.0073066-Wang1].

Sequence Alignment {#s4e}
------------------

For each unique ST the sequences of eight housekeeping loci were concatenated to produce an in-frame sequence of 4,785 bp. Multiple sequence alignment was generated with the ClustalW algorithm and BioEdit software [@pone.0073066-Hall1] by using default parameters, followed by manual inspection. The alignment was made on the translated amino acid sequences and then back-translated to nucleotide sequences to ensure in-frame alignment.

Phylogenetic Analysis {#s4f}
---------------------

Maximum likelihood (ML) and maximum parsimony (MP) trees were constructed using PhyML 3.0 [@pone.0073066-Guindon1] and MEGA 5.05 [@pone.0073066-Tamura1], respectively. To construct the ML tree, the optimal maximum likelihood model of nucleotide substitution was determined using jModeltest [@pone.0073066-Posada1], a neighbor-joining starting tree, nearest-neighborhood interchange and subtree pruning and regrafting. Approximate likelihood ratios (aLRT) were calculated using the Shimodaira-Hasegawa (SH)-like procedure. Rate heterogeneity among sites was examined assuming a discrete gamma distribution with eight rate categories. For the MP tree only parsimony informative sites were used, with 20 replicates of random taxa addition, and close-neighbor-interchange branch swapping. Support for internal nodes was estimated by the nonparametric bootstrap method, with 1,000 replications under a maximum parsimony criterion. Clonal complexes (CCs) were identified using the goeBURST algorithm implemented in the Phyloviz software [@pone.0073066-Francisco1] and consisted of STs that shared 6 of 8 alleles with at least one other ST in the complex. Major and minor clonal complexes were defined as groups of three or more STs and two STs, respectively. Singletons did not belong to any clonal complex, as they differed from every other ST in the data set at three or more of the eight MLST loci. The goeBURST and phylogenetic tree analyses included STs identified in this study and all previously published STs from the northeastern and upper midwestern US and adjoining areas of Canada [@pone.0073066-Margos1], [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. The *I. scapularis* nymphs and adults included in the analyses performed in this study were collected off vegetation, pets and humans in the northeastern and upper midwestern US and adjoining areas of Canada between 2004--2008 [@pone.0073066-Ogden1]--[@pone.0073066-Hoen1]. We did not attempt to compare the diversity and/or frequency distribution of STs in Lyme disease patients to that found in questing *I. scapularis* ticks because: *(i)* there was no temporal overlap between tick and patient samples, *(ii)* ticks were collected from much wider geographic areas than clinical samples, and *(iii)* clinical samples from New York were preselected based on their *ospC* major group.

Statistical Analysis {#s4g}
--------------------

To test whether there are significant differences between the allelic profiles of *B. burgdorferi* from the two geographic locations (New York and Wisconsin) a permutation test was performed as described previously [@pone.0073066-Margos1]. Correspondence analysis in STATA SE 11.0 (Statacorp LP, College Station, TX) was used to assess whether the STs, clonal complexes or *ospC* major groups were significantly (P\<0.05) associated with an outcome of localized or disseminated infection. The correspondence analysis of clonal complexes was conducted in three ways using: *(i)* isolates that were members of major and minor clonal complexes, and isolates that were classified as singletons (each singleton was considered a separate clonal complex), *(ii)* isolates that were members of major and minor clonal complexes only, and *(iii)* isolates that belonged to major clonal complexes only. To compare the ability of clonal complexes versus *ospC* major groups to predict disseminated or localized disease, these three analyses were repeated with *ospC* major groups as the explanatory variables. Correspondence analysis was also used to compare the frequency distribution of *ospC* major groups from 291 skin isolates obtained from New York patients during 1991--2005 and published previously [@pone.0073066-Hanincova1], [@pone.0073066-Wormser4] to that from 65 skin isolates obtained from Wisconsin patients and analyzed in the present study. No pre-selection based on *ospC* typing was performed for this set of data. The level of significance was P\<0.05 throughout.

Supporting Information {#s5}
======================

###### 

**Results of correspondence analysis using only isolates belonging to major or minor clonal complexes.** The x-axis indicates the coordinates of the individual data points. Coordinates for all localized and disseminated infection cases are indicated by the filled diamond and filled square respectively. The strength of association of individual clonal complexes (CCs) (graph A) and *ospC* major groups (graph B) with disseminated or localized infection is demonstrated by the position of unfilled triangles on the x-axis relative to the filled square and lozenge, respectively. The degree of influence of individual clonal complexes or *ospC* major groups in the correspondence analysis (their contribution to the total inertia) is shown by their position along the y-axis. Identities of the particularly influential clonal complexes and *ospC* major groups are indicated.
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Click here for additional data file.
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**Properties of** ***B. burgdorferi*** **samples.**
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Click here for additional data file.
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**Results of correspondence analysis assessing differences in frequency of** ***ospC*** **major groups in skin samples of Lyme disease patients from New York and Wisconsin.**

(DOC)
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Click here for additional data file.
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